Relieving ER stress to target NASH-driven hepatocellular carcinoma

Nat Rev Endocrinol. 2019 Feb;15(2):73-74. doi: 10.1038/s41574-018-0145-7.

Saskia Reibe¹, Mark A Febbraio^{2

3}

¹ Division of Diabetes & Metabolism, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
² Division of Diabetes & Metabolism, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. m.febbraio@garvan.org.au.
³ Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia. m.febbraio@garvan.org.au.

No abstract available

Publication types